First Time Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 26.935 EUR 1.11% Market Closed
Updated: Jul 12, 2024
Have any thoughts about
Bayer AG?
Write Note

Bayer AG
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bayer AG
Cost of Revenue Peer Comparison

Comparables:
ATAI
MRK
DMP
PSG

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bayer AG
XETRA:BAYN
Cost of Revenue
-€19.5B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
0%
ATAI Life Sciences NV
NASDAQ:ATAI
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Cost of Revenue
-€8.7B
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-11%
Dermapharm Holding SE
XETRA:DMP
Cost of Revenue
-€408.9m
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Cost of Revenue
-€9.5m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
N/A

See Also

What is Bayer AG's Cost of Revenue?
Cost of Revenue
-19.5B EUR

Based on the financial report for Mar 31, 2024, Bayer AG's Cost of Revenue amounts to -19.5B EUR.

What is Bayer AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
0%

Over the last year, the Cost of Revenue growth was 5%. The average annual Cost of Revenue growth rates for Bayer AG have been -1% over the past three years , -1% over the past five years .